At what time should the heparin infusion be stopped before coronary artery bypass graft (CABG) surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Heparin Infusion Timing Before CABG Surgery

Stop the heparin infusion at least 4 hours before CABG surgery to eliminate residual anticoagulant effect and minimize bleeding risk.

Recommended Timing

Based on the 2022 American College of Chest Physicians guidelines, therapeutic-dose IV unfractionated heparin (UFH) should be stopped ≥4 hours before elective surgery/procedures 1. This recommendation applies directly to CABG surgery when patients are receiving bridging anticoagulation.

Pharmacologic Rationale

UFH has a dose-dependent elimination half-life of approximately 90 minutes (ranging 30-120 minutes depending on anticoagulation intensity at time of interruption) 1. Stopping the infusion 4-6 hours preoperatively allows sufficient time to eliminate residual anticoagulant effect based on these pharmacokinetic properties.

Key Implementation Points

  • Minimum 4-hour window: The guideline specifically suggests stopping UFH ≥4 hours before surgery rather than <4 hours 1
  • Avoid bolus dosing: When resuming UFH postoperatively, avoid bolus doses and use lower-intensity infusions with lower target aPTT than standard full-dose initiation 1
  • Postoperative resumption: Resume UFH ≥24 hours after CABG surgery rather than within 24 hours to reduce bleeding risk 1

CABG-Specific Considerations

For CABG surgery specifically, the FDA labeling indicates patients undergoing total body perfusion for open-heart surgery should receive an initial intraoperative dose of not less than 150 units/kg, with 300 units/kg commonly used for procedures <60 minutes or 400 units/kg for procedures >60 minutes 2. This intraoperative dosing is separate from the pre-operative bridging anticoagulation timing.

Evidence Quality Note

The guideline recommendation carries a conditional strength with very low certainty of evidence 1, as no studies directly assess timing of IV UFH interruption around surgery. However, the recommendation is based on sound pharmacologic principles and represents the best available guidance from a major professional society (American College of Chest Physicians, 2022).

Common Pitfalls to Avoid

  • Don't stop too close to surgery: Stopping <4 hours before surgery may leave residual anticoagulant effect, increasing surgical bleeding risk
  • Don't resume too early: Postoperative resumption within 24 hours increases bleeding complications without clear thrombotic benefit 1
  • Monitor coagulation status: Check aPTT at baseline and ensure normalization before proceeding with surgery 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.